Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 6, 2004
Tumor localization of 16beta-18F-fluoro-5alpha-dihydrotestosterone versus 18F-FDG in patients with progressive, metastatic prostate cancerSteven M Larson, Michael Morris, Ilonka Gunther, et al.
Molecular Cancer Therapeutics|April 18, 2009
The selective hypoxia inducible factor-1 inhibitor PX-478 provides in vivo radiosensitization through tumor stromal effectsDavid L Schwartz, Garth Powis, Arun Thitai-Kumar, et al.
Molecular Imaging and Biology|July 2, 2010
Synthesis and ex vivo autoradiographic evaluation of ethyl-β-D-galactopyranosyl-(1,4')-2'-deoxy-2'-[18F]fluoro-β-D-glucopyranoside--a novel radioligand for lactose-binding protein: implications for early detection of pancreatic carcinomas with PETYunming Ying, Pradip Ghosh, Liwei Guo, et al.
Cancer Research|November 17, 2007
Therapeutic efficacy of a novel focal adhesion kinase inhibitor TAE226 in ovarian carcinomaJyotsnabaran Halder, Yvonne G Lin, William M Merritt, et al.
Plos Pathogens|March 31, 2015
Low doses of imatinib induce myelopoiesis and enhance host anti-microbial immunityRuth J Napier, Brian A Norris, Alyson Swimm, et al.
The Journal of Clinical Investigation|December 7, 2007
An anticancer C-Kit kinase inhibitor is reengineered to make it more active and less cardiotoxicAriel Fernández, Angela Sanguino, Zhenghong Peng, et al.
Nature Biotechnology|March 26, 2003
Serial in vivo imaging of the targeted migration of human HSV-TK-transduced antigen-specific lymphocytesGuenther Koehne, Mikhail Doubrovin, Ekaterina Doubrovina, et al.
Nature Chemical Biology|October 11, 2016
SF2312 is a natural phosphonate inhibitor of enolasePaul G Leonard, Nikunj Satani, David Maxwell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 24, 2009
c-Jun-NH2-kinase-1 inhibition leads to antitumor activity in ovarian cancerPablo Vivas-Mejia, Juliana Maria Benito, Ariel Fernandez, et al.
Nature Metabolism|November 24, 2020
An enolase inhibitor for the targeted treatment of ENO1-deleted cancersYu-Hsi Lin, Nikunj Satani, Naima Hammoudi, et al.
Pageof 5